Gut Microbiota Analysis in IAI Patients With Sepsis-associated Liver Dysfunction

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

January 3, 2022

Primary Completion Date

September 9, 2022

Study Completion Date

September 14, 2022

Conditions
Gut MicrobiotaIntra-abdominal InfectionsAcute Gastrointestinal InjurySepsis-associated Liver Dysfunction
Interventions
BEHAVIORAL

Gut microbiota Analysis

fecal samples were collected per patient on days 1,3 and 7 after ICU admission. All eligible patients were given antibiotics therapy, actively control infection source by puncture drainage or surgery if necessary, as well as other supportive therapy to maintain organ function.

Trial Locations (1)

210008

Nanjing Drum Tower Hospital, Nanjing

All Listed Sponsors
lead

Chinese Medical Association

NETWORK

NCT05628493 - Gut Microbiota Analysis in IAI Patients With Sepsis-associated Liver Dysfunction | Biotech Hunter | Biotech Hunter